Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity
Zahiragic, L, Schliemann, C, Bieker, R, Thoennissen, N H, Burow, K, Kramer, C, Zühlsdorf, M, Berdel, W E, Mesters, R MVolume:
21
Year:
2007
Language:
english
Pages:
3
DOI:
10.1038/sj.leu.2404632
File:
PDF, 120 KB
english, 2007